Europium doped-double sodium bismuth molybdate nanoparticles as contrast agents for luminescent bioimaging and X-ray computed tomography

Roxana Marisol Calderón Olvera,Nuria Nuñez,Daniel Gonzalez-Mancebo,Jose M Monje Moreno,Manuel Jesús Muñoz-Rui,Elisabet Gomez-Gonzalez,Encarnacion Arroyo,Beatriz Torres Herrero,Jesus M de la Fuente,Manuel Ocana
DOI: https://doi.org/10.1039/d2qi02664c
IF: 7.779
2023-02-17
Inorganic Chemistry Frontiers
Abstract:An one-pot method for the synthesis of uniform Eu3+-doped NaBi(MoO4)2 nanoparticles with ellipsoidal shape and tetragonal crystal structure and functionalized with polyacrylic acid is reported for the first time in the literature. The method is based on a homogenous precipitation reaction from solutions in an ethylene glycol/water medium containing proper bismuth, sodium, and molybdate precursors and polyacrylic acid. The luminescent properties (excitation and emission spectra and luminescence lifetime) of such nanoparticles are evaluated for different Eu3+ doping levels finding an intense red emission for all synthesized samples. The X-ray attenuation properties of the nanoparticles have been also analyzed, which resulted to be better than those of a commercial computed tomography contrast agent (iohexol). The nanoparticles dispersibility in a physiological medium was also analyzed finding that they could be well dispersed in 2-(N-Morpholino)ethanesulfonic acid monohydrate medium (pH = 6.5). Finally, the cell viability of such phosphor has been analyzed using MIA-PaCa-2 cells and its in vivo toxicity has been evaluated using the nematode Caenorhabditis Elegans model finding no significant toxicity in both cases up to a nanoparticles concentration of 100 μg·mL-1, which is within the range required for most in vivo applications. The developed Eu3+-doped NaBi(MoO4)2 nanoparticles are, therefore, excellent candidates for their use as bimodal probes for luminescent imaging and X-ray computed tomography.
chemistry, inorganic & nuclear
What problem does this paper attempt to address?